European mid-market private equity firm Inflexion is to sell its investment in Lintbells, a specialist in pet supplements which are sold under the YuMOVE brand name, to to Vetnique Labs, a portfolio company of Gryphon Investors.
The sale marks a highly successful exit for Inflexion Enterprise Fund IV, generating a 5.5x return.
Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ YuMOVE products a joint mobility supplements for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.
Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities, including its expansion of the highly successful direct-to-consumer channel. Inflexion has also supported the successful expansion of Lintbells into the US both organically and through the acquisition of Walkin’ Pets.
In addition to Lintbells, Inflexion has significant experience in the pet-care market with previous successful investments including Medivet and Kynetec.
Can’t stop reading? Read more
AURELIUS exits LSG Asia-Pacific after operational turnaround and margin expansion
AURELIUS exits LSG Asia-Pacific after operational turnaround and margin expansion AURELIUS has...
Ares lands $9.8bn for flagship opportunistic credit strategy
Ares lands $9.8bn for flagship opportunistic credit strategy Ares has raised more than $9.8bn for...
CVC DIF appoints Enrico Del Prete to scale $25bn value-add platform
CVC DIF appoints Enrico Del Prete to scale $25bn value-add platform CVC DIF has appointed Enrico...